Innovopro

Innovopro is an Israeli food‑tech company that develops and sells a chickpea‑based protein platform (not an investment firm) used as a clean‑label, non‑allergenic plant protein ingredient for food manufacturers and formulators. Innovopro’s flagship ingredient is CP‑Pro 70™, a 70% chickpea protein concentrate and related textured and functional chickpea ingredients for dairy, meat‑alternative, egg‑replacement and sports‑nutrition applications[4][1].

High‑Level Overview

• Innovopro builds a chickpea protein ingredient platform (CP‑Pro 70™ plus textured and functional variants) for the B2B food & beverage market[4][1].
  - It serves food manufacturers, product developers and ingredient formulators looking for clean‑label, non‑GMO, soy‑ and gluten‑free protein solutions for plant‑based dairy, meat analogues, egg substitutes, bakery and sports nutrition products[3][1].
  - The product solves problems around allergen limitations (offers a “free‑from” profile), clean‑label demands, functional performance (solubility, emulsification, foaming) and sustainability compared with some animal or highly processed alternatives, enabling manufacturers to reformulate with fewer additives and simpler ingredient lists[3][4][2].
  - Growth momentum: Innovopro launched commercially as the first chickpea‑protein 70% concentrate, has industry recognition (EIT Rising Food Stars, EU Horizon support), U.S. distribution partnerships and pilot/prototyping collaborations (for example with NC Food Innovation Lab) indicating expanding commercial and application reach[4][3][2].

Origin Story

• Innovopro was founded in 2013 by Dr. Ascher Shmulewitz, a physician/engineer motivated by the idea that food can prevent and treat disease; the company is headquartered in Raanana, Israel[4][2].
  - The idea emerged from proprietary extraction/process technology to yield a 70% chickpea protein concentrate that is functional, nutritious and suitable for clean‑label formulations; Innovopro received EU Horizon funding and was selected for EIT Rising Food Stars as it commercialized the ingredient[4][3].
  - Early traction and pivotal moments include being first to market with a commercial chickpea protein concentrate, recognition from European programs (Seal of Excellence, Horizon grant), inclusion in FoodTech 500 lists, and partnerships with product development labs (e.g., NCFIL) to scale U.S. sampling and applications[4][1][2].

Core Differentiators

• Product differentiators: First commercial 70% chickpea protein concentrate (CP‑Pro 70™), textured protein (CP‑Xtura 65™) and egg‑white substitute (CP‑Stabilifoam™) targeted at multiple categories[2][4].
  - Clean‑label / allergen profile: Non‑GMO, soy‑free, gluten‑free and positioned as “free‑from” with minimal additives, enabling short ingredient lists[3][4].
  - Functional performance: Engineered for solubility, strong emulsification and foaming capacity, plus good color/taste profile for food applications[3][4].
  - Sustainability & utilization: Proprietary process claims high overall utilization of chickpea (close to zero‑waste approach) and a lower environmental footprint relative to some animal proteins[5][4].
  - Application support & partnerships: Active collaboration with innovation labs (NCFIL) and in‑house application development capabilities to deliver prototypes and speed customer productization[2][4].

Role in the Broader Tech Landscape

• Trend alignment: Innovopro rides the growth of plant‑based proteins, clean‑label consumer demand, allergen‑free product development and the shift toward sustainable ingredients in food tech[3][4].
  - Why timing matters: Rising consumer demand for plant proteins and regulatory/retailer focus on simple labels give chickpea protein an opening as manufacturers seek non‑soy, non‑pea alternatives amid supply/ingredient diversification needs[3][1].
  - Market forces in their favor: Expansion of plant‑based categories (dairy alternatives, meat analogues, egg replacements), investor and grant support for alternative‑protein innovation, and food manufacturers’ desire for functional, multi‑use ingredients all support adoption[1][4].
  - Influence: By commercializing chickpea protein at scale and proving functional viability across categories, Innovopro helps broaden the ingredient set available to formulators and reduces reliance on a small set of plant proteins (pea, soy), influencing supply chains and formulation strategies[3][1].

Quick Take & Future Outlook

• Near term: Expect continued commercial scaling (expanded distribution, more customer product launches), extension of the ingredient portfolio (starch/proteins variants) and deeper U.S./EU application partnerships to convert prototypes into retail products[4][2].
  - Medium term trends to watch: Ingredient cost & supply of chickpeas, competition from fermentation‑derived proteins and other novel plant proteins, and increasing demand for functionality that mimics animal proteins will shape Innovopro’s growth trajectory[1][3].
  - How influence may evolve: If Innovopro further proves cost‑effective, functional parity and supply scalability, it can become a standard B2B ingredient for clean‑label plant foods, helping manufacturers reduce allergens and simplify labels while supporting sustainability claims[4][3].

Quick factual anchors: founded 2013; founder Dr. Ascher Shmulewitz; flagship CP‑Pro 70™ chickpea protein concentrate; active commercial partnerships and recognition from EU/FoodTech programs[4][1][2].